Guideline
doi: 10.1016/j.vaccine.2007.04.062.
Epub 2007 May 8.
Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data
Affiliations
- PMID: 17553602
- DOI: 10.1016/j.vaccine.2007.04.062
Item in Clipboard
Guideline
Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data
Vaccine.
.
No abstract available
Similar articles
-
Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.Vaccine. 2007 Aug 1;25(31):5803-20. doi: 10.1016/j.vaccine.2007.04.059. Epub 2007 May 11. Vaccine. 2007. PMID: 17548135 No abstract available.
-
Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data.Vaccine. 2007 Aug 1;25(31):5858-74. doi: 10.1016/j.vaccine.2007.04.056. Epub 2007 May 11. Vaccine. 2007. PMID: 17548132 No abstract available.
-
Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.Vaccine. 2007 Aug 1;25(31):5821-38. doi: 10.1016/j.vaccine.2007.04.057. Epub 2007 May 11. Vaccine. 2007. PMID: 17540485 No abstract available.
-
Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.Vaccine. 2004 Jan 26;22(5-6):575-85. doi: 10.1016/j.vaccine.2003.09.005. Vaccine. 2004. PMID: 14741147 Review. No abstract available.
-
Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.Vaccine. 2004 Jan 26;22(5-6):551-6. doi: 10.1016/j.vaccine.2003.09.007. Vaccine. 2004. PMID: 14741143 Review. No abstract available.
Cited by
-
Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.Trials. 2022 Feb 7;23(1):121. doi: 10.1186/s13063-021-05874-6. Trials. 2022. PMID: 35130946 Free PMC article. Clinical Trial.
-
COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.J Prim Care Community Health. 2021 Jan-Dec;12:21501327211024431. doi: 10.1177/21501327211024431. J Prim Care Community Health. 2021. PMID: 34120504 Free PMC article.
-
OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.BMJ Open. 2020 Dec 17;10(12):e042838. doi: 10.1136/bmjopen-2020-042838. BMJ Open. 2020. PMID: 33334840 Free PMC article.
-
Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.Vaccine. 2017 Dec 4;35(48 Pt A):6472-6482. doi: 10.1016/j.vaccine.2017.01.044. Vaccine. 2017. PMID: 29150052 Free PMC article. No abstract available.
-
Safety of Tdap vaccine in pregnant women: an observational study.BMJ Open. 2016 Apr 18;6(4):e010911. doi: 10.1136/bmjopen-2015-010911. BMJ Open. 2016. PMID: 27091823 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
